다우존스 지수

실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
ENDRA Life Sciences Inc (NDRA)
ENDRA Life Sciences Inc (NDRA) 뉴스

NDRA

ENDRA Life Sciences (NDRA)

ENDRA Life Sciences Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:NDRA

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/15	05:26	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:NDRA	ENDRA Life Sciences Inc
2024/05/15	05:17	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NDRA	ENDRA Life Sciences Inc
2024/05/15	05:05	Business Wire	ENDRA Life Sciences Reports First Quarter 2024 Financial Results and Provides a Business Update	NASDAQ:NDRA	ENDRA Life Sciences Inc
2024/05/11	06:18	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NDRA	ENDRA Life Sciences Inc
2024/05/11	06:17	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:NDRA	ENDRA Life Sciences Inc
2024/05/07	21:00	Business Wire	ENDRA Life Sciences to Report First Quarter 2024 Financial Results on May 14, 2024	NASDAQ:NDRA	ENDRA Life Sciences Inc
2024/05/02	21:00	Business Wire	ENDRA Life Sciences Strengthens Intellectual Property with Issuance of Five New International Patents	NASDAQ:NDRA	ENDRA Life Sciences Inc
2024/03/29	05:05	Business Wire	ENDRA Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update	NASDAQ:NDRA	ENDRA Life Sciences Inc
2024/03/21	21:00	Business Wire	ENDRA Life Sciences to Report Fourth Quarter 2023 Financial Results on March 28, 2024	NASDAQ:NDRA	ENDRA Life Sciences Inc
2024/02/27	22:00	Business Wire	ENDRA Life Sciences Installs First TAEUS System in the UK	NASDAQ:NDRA	ENDRA Life Sciences Inc
2024/02/24	07:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NDRA	ENDRA Life Sciences Inc
2024/02/21	22:00	Business Wire	New ICD-10-CM Code by the World Health Organization Paves the Way for Improved NAFLD Diagnostics Including ENDRA Life Sciences’ TAEUS System	NASDAQ:NDRA	ENDRA Life Sciences Inc
2024/02/14	22:30	Business Wire	ENDRA Life Sciences Bolsters TAEUS® System Intellectual Property with New Patents in U.S., China and Europe	NASDAQ:NDRA	ENDRA Life Sciences Inc
2023/12/30	07:07	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:NDRA	ENDRA Life Sciences Inc
2023/11/29	22:00	Business Wire	ENDRA Life Sciences Secures 39th U.S. Patent for TAEUS® System Technology	NASDAQ:NDRA	ENDRA Life Sciences Inc
2023/11/27	22:00	Business Wire	ENDRA Life Sciences to Participate in The Benchmark Company’s 12th Annual Discovery One-on-One Investor Conference	NASDAQ:NDRA	ENDRA Life Sciences Inc
2023/11/15	06:05	Business Wire	ENDRA Life Sciences Reports Third Quarter 2023 Financial Results and Provides Business Update	NASDAQ:NDRA	ENDRA Life Sciences Inc
2023/11/15	06:02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NDRA	ENDRA Life Sciences Inc
2023/11/08	22:00	Business Wire	ENDRA Life Sciences Achieves Intellectual Property Milestone with Issuance of Three New Patents	NASDAQ:NDRA	ENDRA Life Sciences Inc
2023/11/08	06:05	Business Wire	ENDRA Life Sciences to Report Third Quarter 2023 Financial Results on November 14, 2023	NASDAQ:NDRA	ENDRA Life Sciences Inc
2023/11/06	22:00	Business Wire	ENDRA to Host Multidisciplinary Clinical Discussion on Managing Liver Disease During AASLD’s The Liver Meeting® 2023	NASDAQ:NDRA	ENDRA Life Sciences Inc
2023/09/07	21:00	Business Wire	Abstract for ENDRA Life Sciences' TAEUS System Accepted for Presentation at EASL Steatotic Liver Disease Summit 2023	NASDAQ:NDRA	ENDRA Life Sciences Inc
2023/08/30	21:00	Business Wire	ENDRA Life Sciences' TAEUS De Novo Submission Advances to Next Stage of Review with FDA	NASDAQ:NDRA	ENDRA Life Sciences Inc
2023/08/23	21:00	Business Wire	ENDRA Life Sciences Expands Intellectual Property with Issuance of U.S. and European Patents	NASDAQ:NDRA	ENDRA Life Sciences Inc
2023/08/15	05:53	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:NDRA	ENDRA Life Sciences Inc
2023/08/15	05:45	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:NDRA	ENDRA Life Sciences Inc
2023/08/15	05:13	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NDRA	ENDRA Life Sciences Inc
2023/08/15	05:05	Business Wire	ENDRA Life Sciences Reports Second Quarter 2023 Financial Results and Provides a Business Update	NASDAQ:NDRA	ENDRA Life Sciences Inc
2023/08/15	02:30	Business Wire	ENDRA Life Sciences Submits De Novo Request for its TAEUS® System Liver Fat Application to the U.S. FDA	NASDAQ:NDRA	ENDRA Life Sciences Inc
2023/08/10	21:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NDRA	ENDRA Life Sciences Inc

검색 관련기사 보기:NASDAQ:NDRA

1 2 3 4 5 6 7 8 9 10 다음 >>

FTSEurofirst 300 Medical...

Hang Seng Bank (PK)

Decade Resources

Diamond Boyz Coin

CAC 40 NR Inflation Adju...

American Virtual Cloud T... (PK)

Evolve US Banks Enchance...

Bnp Paribas Issuance

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관